Jury Finds In Favor Of Monsanto In Patent Case Involving Bayer CropScience And Insect-Protected Corn Technology
Monsanto Company announced that a jury has found in favor of Monsanto in a patent infringement and validity case related to insect-protection technology in corn. The jury found that Monsanto did not infringe U.S. Patent No. 5,545,565 assigned to Bayer CropScience. The jury also found that this patent was invalid.
"The jury's findings are further confirmation that Monsanto's scientists were the first to invent the Bacillus thuringiensis (Bt) insect-resistant corn technology and prove that it works," said Robert T. Fraley, Ph.D., executive vice president and chief technology officer for Monsanto. "
Monsanto Company first brought insect-protected corn to the marketplace in the form of YieldGard Corn Borer in 1997. In a lawsuit filed against some of Monsanto's technology licensees in August 2000, Bayer CropScience alleged that the technology used in YieldGard Corn Borer infringed four of their patents.
On Dec. 4, 2000, Monsanto filed suit in the U.S. District Court for the Eastern District of Missouri in St. Louis for a declaratory judgment against Bayer CropScience that four patents, assigned to Bayer CropScience, involving claims to truncated Bt technology were invalid and not infringed by MON 810 in YieldGard corn.
Bayer CropScience counterclaimed to request royalties for prior sales of YieldGard corn and injunctive relief. On June 22, 2004, Bayer CropScience dismissed its claims on three of the four patents in dispute, leaving only the one in this case to be litigated.
Other news from the department politics & laws
Most read news
More news from our other portals
Last viewed contents
DSM and BRAIN cooperate in the biotechnological production of water-soluble vitamins
Bayer: Strategic progress in challenging business environment - Bill Anderson: “We're tackling challenges head on and making progress on our strategic priorities”
Quintiles, London Genetics ally to enhance drug discovery and development through pharmacogenetics - Alliance combines world-class expertise and global infrastructure to support biopharma in the development of personalized medicine
The smell of food controls cellular recycling and affects life expectancy
Mechanism discovered how the coronavirus hijacks the cell - A starting point for vaccine and drug development
Meat, especially if it's well done, may increase risk of bladder cancer - Genetic variants in metabolism pathway further raise likelihood
